Multivoxel Proton Magnetic Resonance Spectroscopy Research Articles

Proton magnetic resonance spectroscopy of brain-stem lesions.

The imaging findings of brain-stem lesions are often nonspecific and histological diagnosis is limited because of fear of complications associated with biopsy. A noninvasive method for tissue characterization is therefore highly desirable. We undertook a review of proton magnetic resonance spectroscopy (MRS) of patients with solitary brain-stem lesions to determine if MRS could characterize them. We carried out single- or multivoxel proton MRS using long echo times (135 or 270 ms) on 34 patients with solitary brain-stem lesions. We analyzed the following peaks: choline (Cho), creatine (Cr), N-acetylaspartate (NAA), and lipids/lactate (Lip) and calculated peak height ratios for Cho/Cr, NAA/Cr and Lip/Cr. The results were compared with histology in nine patients and with the presumptive diagnosis in 25. We also performed single-voxel proton MRS on the brain stem of five normal volunteers. There were differences in all ratios between controls and the patients with neoplastic and non-neoplastic lesions: Cho/Cr was low in non-neoplastic and high in neoplastic lesions (control: 1.8+/-0.1; non-neoplastic: 1.4+/-0.2; neoplastic: 2.0+/-0.2); NAA/Cr was low in non-neoplastic, and lower in neoplastic lesions (control: 2.3+/-0.1; non-neoplastic: 1.4+/-0.2; neoplastic: 1.2+/-0.1), and Lip/Cr was elevated in both neoplastic and non-neoplastic lesions (control: 0.04+/-0.02; nonneoplastic: 1.9+/-0.7; neoplastic:1.9+/-0.7).

Correlation between proton magnetic resonance spectroscopic lactate measurements and vascular reactivity in chronic occlusive cerebrovascular disease: a comparison with positron emission tomography

The purpose of this study is to investigate the correlation between lactate levels and cerebral vascular reactivity (VR) in regions outside an area of chronic cerebral infarction. Multivoxel proton magnetic resonance spectroscopy ( 1H-MRS) and positron emission tomography (PET) were performed in 11 patients who suffered chronic cerebral infarction. Of these 11 patients, 4 were examined before and after bypass surgery. Two regions-of-interests (ROIs) were placed outside the area of chronic infarction. One ROI was placed within a control region on the contralateral side. A lactate peak area was obtained in all ROIs. An N-acetyl aspartate (NAA) peak area was obtained in the ROI within the control region. The ratio of the lactate peak area and NAA peak area (Lct/NAA) was calculated for normalization of the lactate level, and was found to be 0.13 ± 0.10 (range, 0 to 0.43). The VR was recorded at 13.3 ± 20.7% (range, - 44.3 to 68.9%), utilizing PET and administering acetazolamide. A significant negative correlation was observed between the Lct/NAA ratio and VR ( r = - 0.709, p < 0.0001). These results suggest that lactate levels and VR are closely related in regions outside areas of chronic cerebral infarction.

A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.

Animal studies have suggested an increased striatal glutamate activity in Parkinson's disease models, although this has not been substantiated in magnetic resonance spectroscopy studies in patients. Our initial aim was to assess glutamate and glutamine levels in the striatum of patients with idiopathic Parkinson's disease, using multivoxel proton magnetic resonance spectroscopy techniques. Since data were collected from other areas of the brain without a priori selection, information on the cortex was also obtained. Twelve healthy volunteers, seven dyskinetic and five non-dyskinetic patients were studied. Peak area ratios of choline-containing compounds (Cho), glutamine and glutamate (Glx) and N-acetyl moieties including N-acetylaspartate (NAx), relative to creatine (Cr) were calculated. Spectra were analysed from the corpus striatum, the occipital cortex and the temporo-parietal cortex. The median Glx/Cr ratio was unaltered in the striatal spectra of Parkinson's disease patients compared to healthy controls. However, the more severely affected patients had significantly reduced NAx/Cr ratios in spectra localised to the temporo-parietal cortex, compared to healthy controls. Furthermore, the entire patient population had significantly reduced Cho/Cr ratios in spectra from the temporo-parietal cortex, compared to the reference population. We found no evidence of increased striatal glutamate in either dyskinetic or non-dyskinetic Parkinson's disease. However, the low NAx/Cr and Cho/Cr ratios in the temporo-parietal cortex may indicate the presence of subclinical cortical dysfunction.

1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities.

To analyze brain metabolite changes in HIV-1-seropositive subjects in order to define whether the neuronal impairment is a localized or more diffuse process. 15 patients and 18 volunteers underwent multivoxel proton magnetic resonance (MR) spectroscopy at 1.5T. Nine patients were classified as being neuropsychiatrically unimpaired and six as having HIV-1-associated dementia on the basis of a full neuropsychological examination. Spectra were analysed from multiple voxels located in the fronto-parietal cortex and white matter at the level of centrum semiovale. A significant reduction in mean peak area ratios of NAA/Cr (p<0.005 in the grey matter, p<0.01 in the white matter) and an elevation in mean Cho/Cr (p<0.005 in both grey matter and white matter) were observed in patients with HIV-1-associated dementia when compared to healthy volunteers. No significant metabolite abnormalities were detected in the neuropsychiatrically unimpaired group, although there was a similar trend in the metabolite ratios. The changes in metabolite ratios were of the same order of magnitude in the cortical grey matter and subcortical white matter as in the deeper white matter in all patients. There were also no significant regional variations in mean metabolite ratios between right and left hemispheres or anterior and posterior voxels at the level of the brain studied. There were no abnormalities in Glx/Cr in any spectra analysed from either patient group. The absence of significant regional variation in metabolite ratios at the level of the centrum semiovale provides some evidence that abnormalities of cerebral metabolites in HIV-infected patients may be part of a diffuse process.